Loading insider details...
Beta
Latest Form 4 (Aug 5, 2026): Exercise/Conversion of 2,255 GH shares, $205.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | Guardant Health, Inc. (GH) | Exercise/Conversion | 2,255 | $205.5K |
| Jun 23, 2026 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/Award | 29,500 | n/a |
| Jun 22, 2026 | Guardant Health, Inc. (GH) | Exercise/Conversion | 5,092 | n/a |
| Jun 15, 2026 | Corvus Pharmaceuticals, Inc. (CRVS) | Grant/Award | 15,000 | n/a |
| Jun 4, 2026 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/Award | 7,490 | n/a |
| May 29, 2026 | Kyverna Therapeutics, Inc. (KYTX) | Grant/Award | 5,093 | n/a |
| May 22, 2026 | Guardant Health, Inc. (GH) | Sale | 6,876 | $735.0K |
| Dec 24, 2025 | Olema Pharmaceuticals, Inc. (OLMA) | Exercise/Conversion | 209,690 | $923.9K |
| Dec 9, 2025 | Guardant Health, Inc. (GH) | Exercise/Conversion | 9,105 | $349.8K |
| Aug 5, 2025 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/Award | 7,000 | n/a |